The Medicines Access Portal (MAP) is a single, secure online portal that allows clinicians to view the Compassionate Access Programs and Special Access Programs that pharmaceutical companies have available for cancer patients in Australia.
Why it was developed
Access programs are not publicly advertised and are difficult and time consuming to uncover individually. Traditionally, clinicians have had to rely on general knowledge or word-of-mouth to access, or even be aware of, new and potentially life-saving treatments for their patients.
The Australian-first MAP portal, developed by RCA and Medicines Australia (MA), lists these access programs in one central location. This makes it faster and easier for busy clinicians, including those in regional areas, to learn about the latest treatment options for their patients with complex, life-limiting cancer.
The MAP is approved and endorsed by the Therapeutic Goods Administration (TGA) and is available to AHPRA-registered medical practitioners and oncology pharmacists only.
If you have any questions about the MAP, please contact us at [email protected]
“I will definitely continue to use and recommend MAP. It is so easy to find possible programs for patients all in the one place.” – Cancer clinician
Introducing this option
If you are a patient or carer searching for treatment options, your cancer doctors may not yet be aware of the MAP. If you’d like them to explore this option, you can show them this Medicines Access Portal (MAP) Information Booklet
